Back
Fennec Pharmaceuticals, Inc. Vs. Insmed, Inc. Industry Stock Comparison
Sell
23
FRX.TO
Fennec Pharmaceuticals, Inc.
Last Price:
$10.39
Seasonality Move:
17.23%
Sell
40
INSM
Insmed, Inc.
Last Price:
$174.52
Seasonality Move:
7.61%
Sell
23
Fennec Pharmaceuticals, Inc. (FRX.TO)
is a Sell
Is Fennec Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Fennec Pharmaceuticals, Inc. [FRX.TO] share price is $10.39. The Score for FRX.TO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
FRX.TO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Insmed, Inc. (INSM)
is a Sell
Is Insmed, Inc. a Buy, Sell or Hold?
-
The current Insmed, Inc. [INSM] share price is $166.55. The Score for INSM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
INSM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FRX.TO Stock Price Chart
What is Fennec Pharmaceuticals, Inc.'s stock price today?
-
The Fennec Pharmaceuticals, Inc. share price today is $10.39Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FRX.TO is experiencing slight buying pressure.
INSM Stock Price Chart
What is Insmed, Inc.'s stock price today?
-
The Insmed, Inc. share price today is $166.55Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INSM is experiencing slight selling pressure.
FRX.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.3 | Sell |
| Relative Strength Index (14 RSI): | 33.6 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.4 - 11.62) | Sell |
| Bollinger Bands (100): | (10.98 - 12.56) | Sell |
INSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 29.93 | Sell |
| Chaikin Money Flow: | -270452 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (190.54 - 208.08) | Sell |
| Bollinger Bands (100): | (130.7 - 191.18) | Buy |
FRX.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.53 | Sell |
| 20-day SMA: | 10.76 | Sell |
| 50-day SMA: | 11.4 | Sell |
| 200-day SMA: | 10.83 | Sell |
| 8-day EMA: | 10.52 | Sell |
| 20-day EMA: | 10.78 | Sell |
| 50-day EMA: | 11.25 | Sell |
| 200-day EMA: | 10.96 | Sell |
INSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 192.36 | Sell |
| 20-day SMA: | 199.79 | Sell |
| 50-day SMA: | 186.64 | Sell |
| 200-day SMA: | 121.17 | Buy |
| 8-day EMA: | 191.25 | Sell |
| 20-day EMA: | 194.86 | Sell |
| 50-day EMA: | 184.92 | Sell |
| 200-day EMA: | 135.61 | Buy |
Fennec Pharmaceuticals, Inc. Earnings Growth & FRX.TO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and an increase next year of $1.27 per share.
Insmed, Inc. Earnings Growth & INSM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.80 per share, and an increase next year of $2.60 per share.
Fennec Pharmaceuticals, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Insmed, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||